Literature DB >> 7977121

Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy.

J F Carlquist1, R H Ward, D Husebye, M Feolo, J L Anderson.   

Abstract

Certain immunologic features associated with idiopathic dilated cardiomyopathy (IDC) suggest an infectious and/or autoimmune etiology. In this regard, an association between the major histocompatibility complex class II allele, DR4, and increased risk for IDC was previously identified. In the present report, 43 additional patients with IDC and 236 control subjects were studied for major histocompatibility class II allele associations. DR alleles were identified by microcytotoxicity. No significant differences between control subjects and patients with IDC were seen, although the frequency of DR4 was increased among patients. DR4 subtyping (n = 9) was performed by "dot blot" hybridization of allele-specific oligonucleotide probes to PCR-amplified genomic deoxyribonucleic acid. The DRB1*0401 and DRB1*0404 alleles were each found in 44% (n = 4) of patients with IDC, and DRB1*0407 was identified in 1 patient (11%). DQ and DP alleles were identified by restriction endonuclease codigestion of polymerase chain reaction-amplified deoxyribonucleic acid. The digested fragments were separated and identified by polyacrylamide gel electrophoresis. Differences between patients and control subjects were observed for DQA1*0501 (11% of patients vs 28% of control subjects, p < 0.05) and DQB1*0201 (13% patients vs 25% control subjects, p < 0.05). A modest difference was noted for DQA1*0301 (35% patients vs 23% control subjects, p = 0.08). These findings suggest a complex immune-related etiology for IDC that cannot be explained solely by the presence or absence of a single class II allele. However, this and other studies continue to implicate genes within the class II region in determining the risk for IDC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977121     DOI: 10.1016/0002-9149(94)90586-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

Authors:  Bo Jin; Xin-Ping Luo; Huan-Chun Ni; Wei Shen; Hai-Ming Shi; Yong Li
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

2.  Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy.

Authors:  N de Leeuw; W J Melchers; D J Ruiter; A L Caforio; A H Balk; N de Jonge; J M Galama
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

3.  Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice.

Authors:  John F Elliott; Junliang Liu; Zuan-Ning Yuan; Norma Bautista-Lopez; Sarah L Wallbank; Kunimasa Suzuki; David Rayner; Patrick Nation; Murray A Robertson; Gang Liu; Katherine M Kavanagh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-21       Impact factor: 11.205

Review 4.  Genetic complexity of autoimmune myocarditis.

Authors:  Haiyan S Li; Davinna L Ligons; Noel R Rose
Journal:  Autoimmun Rev       Date:  2007-12-03       Impact factor: 9.754

Review 5.  HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy.

Authors:  B Jin; B W Wu; Z C Wen; H M Shi; J Zhu
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.